Literature DB >> 28400627

Molecular subtypes in cancers of the gastrointestinal tract.

Maarten F Bijlsma1, Anguraj Sadanandam2, Patrick Tan3, Louis Vermeulen1.   

Abstract

Malignancies of the gastrointestinal tract are among the most common human cancers. The distinct tissues of origin give rise to a diverse set of diseases, such as colorectal cancer, pancreatic carcinoma and gastric cancers, with each associating with specific clinical features. Genomic and transcriptomic analyses have further defined the heterogeneity that occurs within these cancers by identifying so-called molecular subtypes. These subtypes are characterized by specific genetic aberrations and expression signatures that suggest important biological differences. Although at first sight this subdivision of organ-specific cancers might increase the complexity of classification, closer analysis suggests that the subtypes detected in the various malignancies are recurring. For example, nearly all gastrointestinal cancers appear to present with subtypes that are either characterized by a mesenchymal gene expression signatures, extensive immune infiltration or metabolic dysregulation. Additionally, in each of the gastrointestinal malignancies, a 'canonical' subtype is recognized that retains characteristic features of the epithelial tissue of origin. These common themes can enhance our collective understanding of these malignancies, and could perhaps be therapeutically exploited. In this Review, the identification of subtypes in the various gastrointestinal cancer types are discussed along with how they could be incorporated into clinical practice.

Entities:  

Mesh:

Year:  2017        PMID: 28400627     DOI: 10.1038/nrgastro.2017.33

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  103 in total

Review 1.  Stem cell dynamics in homeostasis and cancer of the intestine.

Authors:  Louis Vermeulen; Hugo J Snippert
Journal:  Nat Rev Cancer       Date:  2014-06-12       Impact factor: 60.716

2.  Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors.

Authors:  Shinichi Yachida; Catherine M White; Yoshiki Naito; Yi Zhong; Jacqueline A Brosnan; Anne M Macgregor-Das; Richard A Morgan; Tyler Saunders; Daniel A Laheru; Joseph M Herman; Ralph H Hruban; Alison P Klein; Siân Jones; Victor Velculescu; Christopher L Wolfgang; Christine A Iacobuzio-Donahue
Journal:  Clin Cancer Res       Date:  2012-09-18       Impact factor: 12.531

Review 3.  Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.

Authors:  Jessica Zucman-Rossi; Augusto Villanueva; Jean-Charles Nault; Josep M Llovet
Journal:  Gastroenterology       Date:  2015-06-20       Impact factor: 22.682

4.  Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Authors:  Eric Raymond; Laetitia Dahan; Jean-Luc Raoul; Yung-Jue Bang; Ivan Borbath; Catherine Lombard-Bohas; Juan Valle; Peter Metrakos; Denis Smith; Aaron Vinik; Jen-Shi Chen; Dieter Hörsch; Pascal Hammel; Bertram Wiedenmann; Eric Van Cutsem; Shem Patyna; Dongrui Ray Lu; Carolyn Blanckmeister; Richard Chao; Philippe Ruszniewski
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

Review 5.  Oncotype DX(®) colon cancer assay for prediction of recurrence risk in patients with stage II and III colon cancer: A review of the evidence.

Authors:  Y Nancy You; Rudolph B Rustin; James D Sullivan
Journal:  Surg Oncol       Date:  2015-02-14       Impact factor: 3.279

6.  Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer.

Authors:  Eric Van Cutsem; Heinz-Josef Lenz; Claus-Henning Köhne; Volker Heinemann; Sabine Tejpar; Ivan Melezínek; Frank Beier; Christopher Stroh; Philippe Rougier; J Han van Krieken; Fortunato Ciardiello
Journal:  J Clin Oncol       Date:  2015-01-20       Impact factor: 44.544

7.  Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.

Authors:  Zhengdeng Lei; Iain Beehuat Tan; Kakoli Das; Niantao Deng; Hermioni Zouridis; Sharon Pattison; Clarinda Chua; Zhu Feng; Yeoh Khay Guan; Chia Huey Ooi; Tatiana Ivanova; Shenli Zhang; Minghui Lee; Jeanie Wu; Anna Ngo; Sravanthy Manesh; Elisabeth Tan; Bin Tean Teh; Jimmy Bok Yan So; Liang Kee Goh; Alex Boussioutas; Tony Kiat Hon Lim; Horst Flotow; Patrick Tan; Steven G Rozen
Journal:  Gastroenterology       Date:  2013-05-14       Impact factor: 22.682

8.  Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer.

Authors:  Marc Peeters; Kelly S Oliner; Timothy J Price; Andrés Cervantes; Alberto F Sobrero; Michel Ducreux; Yevhen Hotko; Thierry André; Emily Chan; Florian Lordick; Cornelis J A Punt; Andrew H Strickland; Gregory Wilson; Tudor E Ciuleanu; Laslo Roman; Eric Van Cutsem; Pei He; Hua Yu; Reija Koukakis; Jan-Henrik Terwey; Andre S Jung; Roger Sidhu; Scott D Patterson
Journal:  Clin Cancer Res       Date:  2015-09-04       Impact factor: 12.531

9.  An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell Carcinoma.

Authors:  Genta Sawada; Atsushi Niida; Hidenari Hirata; Hisateru Komatsu; Ryutaro Uchi; Teppei Shimamura; Yusuke Takahashi; Junji Kurashige; Tae Matsumura; Hiroki Ueo; Yuki Takano; Masami Ueda; Shotaro Sakimura; Yoshiaki Shinden; Hidetoshi Eguchi; Tomoya Sudo; Keishi Sugimachi; Makoto Yamasaki; Fumiaki Tanaka; Yuji Tachimori; Yoshiaki Kajiyama; Shoji Natsugoe; Hiromasa Fujita; Yoichi Tanaka; George Calin; Satoru Miyano; Yuichiro Doki; Masaki Mori; Koshi Mimori
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

10.  Integrated genomic characterization of oesophageal carcinoma.

Authors: 
Journal:  Nature       Date:  2017-01-04       Impact factor: 49.962

View more
  39 in total

Review 1.  Management of Advanced Small Bowel Cancer.

Authors:  Alberto Puccini; Francesca Battaglin; Heinz-Josef Lenz
Journal:  Curr Treat Options Oncol       Date:  2018-11-05

2.  Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.

Authors:  Yang Liu; Nilay S Sethi; Toshinori Hinoue; Barbara G Schneider; Andrew D Cherniack; Francisco Sanchez-Vega; Jose A Seoane; Farshad Farshidfar; Reanne Bowlby; Mirazul Islam; Jaegil Kim; Walid Chatila; Rehan Akbani; Rupa S Kanchi; Charles S Rabkin; Joseph E Willis; Kenneth K Wang; Shannon J McCall; Lopa Mishra; Akinyemi I Ojesina; Susan Bullman; Chandra Sekhar Pedamallu; Alexander J Lazar; Ryo Sakai; Vésteinn Thorsson; Adam J Bass; Peter W Laird
Journal:  Cancer Cell       Date:  2018-04-02       Impact factor: 31.743

Review 3.  Energy balance and gastrointestinal cancer: risk, interventions, outcomes and mechanisms.

Authors:  Cornelia M Ulrich; Caroline Himbert; Andreana N Holowatyj; Stephen D Hursting
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-11       Impact factor: 46.802

4.  Clinical and metabolomics analysis of hepatocellular carcinoma patients with diabetes mellitus.

Authors:  Hongping Xia; Jianxiang Chen; Karthik Sekar; Ming Shi; Tian Xie; Kam M Hui
Journal:  Metabolomics       Date:  2019-11-26       Impact factor: 4.290

Review 5.  Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.

Authors:  Shuji Ogino; Jonathan A Nowak; Tsuyoshi Hamada; Amanda I Phipps; Ulrike Peters; Danny A Milner; Edward L Giovannucci; Reiko Nishihara; Marios Giannakis; Wendy S Garrett; Mingyang Song
Journal:  Gut       Date:  2018-02-06       Impact factor: 23.059

6.  TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas.

Authors:  Tsuyoshi Hamada; Thing Rinda Soong; Yohei Masugi; Keisuke Kosumi; Jonathan A Nowak; Annacarolina da Silva; Xinmeng Jasmine Mu; Tyler S Twombly; Hideo Koh; Juhong Yang; Mingyang Song; Li Liu; Mancang Gu; Yan Shi; Katsuhiko Nosho; Teppei Morikawa; Kentaro Inamura; Sachet A Shukla; Catherine J Wu; Levi A Garraway; Xuehong Zhang; Kana Wu; Jeffrey A Meyerhardt; Andrew T Chan; Jonathan N Glickman; Scott J Rodig; Gordon J Freeman; Charles S Fuchs; Reiko Nishihara; Marios Giannakis; Shuji Ogino
Journal:  Oncoimmunology       Date:  2018-03-19       Impact factor: 8.110

7.  Natural killer cell and stroma abundance are independently prognostic and predict gastric cancer chemotherapy benefit.

Authors:  Bailiang Li; Yuming Jiang; Guoxin Li; George A Fisher; Ruijiang Li
Journal:  JCI Insight       Date:  2020-05-07

8.  The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome.

Authors:  Keisuke Kosumi; Tsuyoshi Hamada; Hideo Koh; Jennifer Borowsky; Susan Bullman; Tyler S Twombly; Daniel Nevo; Yohei Masugi; Li Liu; Annacarolina da Silva; Yang Chen; Chunxia Du; Mancang Gu; Chenxi Li; Wanwan Li; Hongli Liu; Yan Shi; Kosuke Mima; Mingyang Song; Katsuhiko Nosho; Jonathan A Nowak; Reiko Nishihara; Hideo Baba; Xuehong Zhang; Kana Wu; Molin Wang; Curtis Huttenhower; Wendy S Garrett; Matthew L Meyerson; Jochen K Lennerz; Marios Giannakis; Andrew T Chan; Jeffrey A Meyerhardt; Charles S Fuchs; Shuji Ogino
Journal:  Am J Pathol       Date:  2018-09-20       Impact factor: 4.307

9.  Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma.

Authors:  Robert Montal; Daniela Sia; Carla Montironi; Wei Q Leow; Roger Esteban-Fabró; Roser Pinyol; Miguel Torres-Martin; Laia Bassaganyas; Agrin Moeini; Judit Peix; Laia Cabellos; Miho Maeda; Carlos Villacorta-Martin; Parissa Tabrizian; Leonardo Rodriguez-Carunchio; Giancarlo Castellano; Christine Sempoux; Beatriz Minguez; Timothy M Pawlik; Ismail Labgaa; Lewis R Roberts; Manel Sole; Maria I Fiel; Swan Thung; Josep Fuster; Sasan Roayaie; Augusto Villanueva; Myron Schwartz; Josep M Llovet
Journal:  J Hepatol       Date:  2020-03-12       Impact factor: 25.083

10.  Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs).

Authors:  Alberto Puccini; Kelsey Poorman; Mohamed E Salem; Davide Soldato; Andreas Seeber; Richard M Goldberg; Anthony F Shields; Joanne Xiu; Francesca Battaglin; Martin D Berger; Ryuma Tokunaga; Madiha Naseem; Afsaneh Barzi; Syma Iqbal; Wu Zhang; Shivani Soni; Jimmy J Hwang; Philip A Philip; Stefania Sciallero; W Michael Korn; John L Marshall; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2020-09-03       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.